0
Soleno Therapeutics, Inc. Banner Image

Soleno Therapeutics, Inc.

  • Ticker SLNO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Soleno Therapeutics, Inc. Logo Image
  • 1-10 Employees
  • Based in Redwood City, California
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled-Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is currently being evaluated in a Phase III clinical development program.
REPORT RATINGS
4.8 / 5.0 (111)

Soleno Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 111 reviews.

Soleno Therapeutics, Inc.

Most Recent Annual Report

Soleno Therapeutics, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Soleno Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!